Ruberti, A, Cepas-Guillén, P, Echarte-Morales, J, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, MN, Nombela-Franco, L, Pascual, I, Guerreiro, CE, Benito-González, T, Pérez, R, Gomez-Blázquez, I, Amat-Santos, IJ, Flores-Umanzor, E, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Barreiro-Pérez, M, Sanchis, L, Li, CH, Caneiro-Queija, B, del Trigo, M, Martínez-Carmona, JD, Mesa, D, Quevedo, PJ, Avanzas, P, Estévez-Loureiro, R, Freixaa, X. Efficacy of transcatheter edge-to-edge repair for cardiac implantable electronic device-associated tricuspid regurgitation: insights from the TRI-SPA registry. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(10)DOI:10.1016/j.rec.2025.01.010. PMID:39894161. IF:4.900(Q1/2D).

Rodés-Cabau, J, Nombela-Franco, L, Muntané-Carol, G, Veiga, G, Regueiro, A, Nazif, T, Serra, V, Asmarats, L, Ribeiro, HB, Latib, A, Poulin, A, Cheema, AN, Jiménez-Quevedo, P, Gomez-Hospital, JA, Ongay, AG, Gabani, R, Arzamendi, D, Brener, M, Calabuig, A, Scotti, A, Gelain, MAS, Labinaz, M, Cepas-Guillén, P, Nuche, J, Cote, M, Del Portillo, JH, Philippon, F. Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE study. HEART RHYTHM. 2025; 22(10)DOI:10.1016/j.hrthm.2024.12.019. PMID:39694306. IF:5.700(Q1/2D).

Jamhour-Chelh, K, Jimenez-Kockar, M, Fernandez-Peregrina, E, Arzamendi, D. Dissecting ST-Segment Elevation Myocardial Infarction Pathophysiology Through Invasive Physiology: Prognostic Insight or Actionable Clinical Guidance?. CANADIAN JOURNAL OF CARDIOLOGY. 2025; 41(10)DOI:10.1016/j.cjca.2025.07.015. PMID:40680880. IF:5.300(Q1/2D).

Marzo, C, Solanich, T, Tassies, D, Pina, E, Rebollo, MA, Gallardo, E, Serradell, S, Merino, M, Carrasco, M, Tugues, A. Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2595-1811. PMID:40359988. IF:4.300(Q1/2D).

Vilahur, G, Borrell-Pagés, M. Monocyte/Macrophages: Unexpected Allies in the Fight Against Arterial Thrombosis?. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2641-6568. PMID:40614767. IF:4.300(Q1/2D).

Andreadou, I, Ghigo, A, Nikolaou, PE, Swirski, FK, Thackeray, JT, Heusch, G, Vilahur, G. Immunometabolism in heart failure. Nature Reviews Cardiology. 2025; 22(10)DOI:10.1038/s41569-025-01165-8. PMID:40544171. IF:44.200(Q1/1D).

Luquero, A, Pimentel, N, Vilahur, G, Badimon, L, Borrell-Pages, M. Reduced Growth and Inflammation in Lrp5-/- Mice Adipose Tissue. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2025; 29(19)DOI:10.1111/jcmm.70670. PMID:41078090. IF:4.200(Q2/3D).

Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024). MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2025; 608DOI:10.1016/j.mce.2025.112626. PMID:40750504. IF:3.600(Q2/4D).

Alarcón, PP, Alvarez, ED, Goitia, CL, Rodríguez, MM, Urbon, L, Maldonado, A, García, S, Serrallonga, NB, Aviño, LR, Palomar, JMR, Lopez, JG, Hoyas, CIN, Corcoy, R, Raimond, TM, López, ML, Madorell, BS, Hernández, M, Kyriakos, G, Bellas, LC, Borrás, JG, Servant, OS, Colet, AM, Serrano, C, Contreras, C, Román, AR, Díez, M, Veladesojo, A, Andujar, P, Diez, A, Galiana, PA, Peris, BP, Fernandez, E, Ferrer, M, Alfonso, FJG, Torre, ELM. Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study. Diabetes Technology & Therapeutics. 2025; 27(10)DOI:10.1177/15209156251363452. PMID:40729095. IF:6.300(Q1/2D).

Subedi, S, Harris, PN, Chapman, P, Chen, AF, Davis, JS, Liu, PY, Marais, LC, Salles, MJ, Roberts, JA, Rodriguez-Bano, J, Wouthuyzen-Bakker, M, Paterson, DL, Benito, N. A global survey of diagnostic practices in prosthetic joint infections. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2025; 113(2)DOI:10.1016/j.diagmicrobio.2025.116919. PMID:40480080. IF:1.800(Q3/7D).

Iriondo, J, Zubicaray, J, Rio, P, Catala, A, Solsona, M, Sanz, A, Gomez, A, Sebastian, E, de la Cruz, A, Galan, A, Navarro, S, Larcher, L, de Andoin, NG, Uriz, JJ, Vagace, JM, de Pablo, JG, Pujol, MR, Nicoletti, E, Surralles, J, Martin-Prado, S, Schwartz, JD, Soulier, J, Bueren, JA, Sevilla, J. Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREV. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 115(4)DOI:10.1111/ejh.70007. PMID:40665878. IF:2.300(Q2/5D).

de la Peña, FA, Martínez-Ramos, D, Juan-Vidal, O, Gómez-Balaguer, M, Miguélez, M, Páez, D, Arrazubi, V, González, CH. Oncological needs in transgender patients. Clinical & Translational Oncology. 2025; 27(10)DOI:10.1007/s12094-025-03917-x. PMID:40251439. IF:2.500(Q3/6D).

Suárez, C, Torras, OR, Barrera, RM, Sánchez, AR, Palacios, GA, Manshino, AMB, Núñez, NF, Vidal, MJM, Carbonero, IG, Calvo, OF, Sarrió, RG, Herrero, GC, Afonso, JA, Fita, MJJ, Padró, JG, Quintela, ML, Rodriguez-Vida, A, Perez, CH, Colmenero, AM, Martin, RC, de España, CG, Palau, CM, Ortega, EM, Gallardo, E. Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study. Clinical Genitourinary Cancer. 2025; 23(5)DOI:10.1016/j.clgc.2025.102402. PMID:40830022. IF:2.700(Q2/3D).

Palmerini, E, Meazza, C, Tamburini, A, Márquez-Vega, C, Bisogno, G, Fagioli, F, Ferraresi, V, Milano, GM, Coccoli, L, Rubio-San-Simón, A, Gallego, O, Riestra, MEL, Manzitti, C, Mora, J, Vaz-Salgado, MA, Luksch, R, Mata, C, Pierini, M, Carretta, E, Cesari, M, Paioli, A, Marrari, A, Scotlandi, K, Serra, M, Asaftei, SD, Gambarotti, M, Picci, P, Ferrari, S, Valverde, C, Ibrahim, T, Broto, JM. Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(28)DOI:10.1200/JCO-25-00210. PMID:40825172. IF:41.900(Q1/1D).

Tibau, A, Romano, A, Liu, ITT, Han, J, Cliff, ERS, Kesselheim, AS. Assessing outcomes emerging after conversion to regular approval for cancer drug indications granted accelerated approval, 1992-2021. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025; 117(10)DOI:10.1093/jnci/djaf195. PMID:40690366. IF:7.200(Q1/2D).

López-Fernández, A, Pardo, M, Pérez-Ballestero, E, Darder, E, Alfonso, R, Torres-Esquius, S, Garcés, VN, Cajal, TRY, Brunet, J, Balmaña, J. Exploring communication preferences for disclosing breast cancer risk in women with a family history. Journal of Genetic Counseling. 2025; 34(5)DOI:10.1002/jgc4.70114. PMID:40965181. IF:1.900(Q2/5D).

Fumagalli, C, Mozos, A, Szafranska, J, Orellana, R. Metastatic melanoma mimicking an angiomatoid fibrous histiocytoma. Revista Espanola De Patologia. 2025; 58(4)DOI:10.1016/j.patol.2025.100841. PMID:40902304. IF:(Q/D).

Recalde-Percaz, L, de la Guia-lopez,, Linzoain-Agos, P, Noguera-Castells, A, Rodrigo-Faus, M, Jauregui, P, Lopez-Plana, A, Fernández-Nogueira, P, Iniesta-González, M, Cueto-Remacha, M, Manzano, S, Alonso, R, Moragas, N, Baquero, C, Palao, N, Dalla, F, Avilés-Jurado, FX, Vilaseca,, León-Vintró, X, Camacho, M, Fuster, G, Alcaraz, J, Aguirre-Ghiso, J, Gascón, P, Porras, A, Gutiérrez-Uzquiza, A, Carbó, N, Bragado, P. Neuropilin-2 upregulation by stromal TGFß1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth. NEOPLASIA. 2025; 68DOI:10.1016/j.neo.2025.101220. PMID:40848614. IF:7.700(Q1/2D).

Fasanella, MG, Mozos, A, Briones, J, Nomdedeu, JF, Novelli, S. Evaluation of Clinical Outcomes and Treatment Complications in Hairy Cell Leukemia: A Single-Center Retrospective Analysis. Cancer Reports. 2025; 8(10)DOI:10.1002/cnr2.70356. PMID:41031578. IF:(Q/D).

Puig Campmany M, Martin-Fumadó C, Pujol-Robinat A, Arimany-Manso J. Clinical-assistance and medical-legal aspects of the use of electric weapons.. MEDICINA CLINICA. 2025; 165(4)DOI:10.1016/j.medcli.2025.107121. PMID:40680410. IF:(Q/D).